BioWorld

Nov. 21, 2016

View Archived Issues

Money raised by biotech: Jan. 1 - Nov. 17, 2016

Money raised by biotech in 2016 vs. 2015

BioWorld stock report for public biotechnology companies

The week's biggest gainers and losers

Biopharmaceutical modified and terminated agreements: October 21 - November 17, 2016

Biopharmaceutical collaborations: October 21 - November 17, 2016

Top biopharmaceutical collaborations in 2016

Word on the street

Week in review

Week in Washington

Make sure you 'nose' how to take that drug

Intranasal drug delivery isn't just for stuffy noses. Multiple drugs delivered through the nose have been approved in the past year despite not treating diseases of the nose. Read More

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...